Tower Research Capital LLC (Trc) Vericel Corp Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Vericel Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,357 shares of VCEL stock, worth $192,221. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,357

Previous 12,295 72.7%

Holding current value

$192,221

Previous $564,000 75.0%

% of portfolio

0.0%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$42.25 - $53.56 $377,630 - $478,719	-8,938 Reduced 72.7%	3,357 $141,000
Q2 2024 Aug 13, 2024	BUY	$41.71 - $52.9 $492,303 - $624,378	11,803 Added 2398.98%	12,295 $564,000
Q1 2024 May 15, 2024	SELL	$32.52 - $52.33 $234,339 - $377,089	-7,206 Reduced 93.61%	492 $25,000
Q4 2023 Feb 13, 2024	BUY	$30.85 - $37.09 $157,026 - $188,788	5,090 Added 195.17%	7,698 $274,000
Q3 2023 Nov 14, 2023	BUY	$31.69 - $39.25 $30,168 - $37,366	952 Added 57.49%	2,608 $87,000
Q2 2023 Aug 14, 2023	SELL	$29.0 - $38.37 $348 - $460	-12 Reduced 0.72%	1,656 $62,000
Q1 2023 May 09, 2023	BUY	$23.85 - $31.34 $25,281 - $33,220	1,060 Added 174.34%	1,668 $49,000
Q4 2022 Feb 10, 2023	SELL	$17.65 - $27.37 $205,587 - $318,805	-11,648 Reduced 95.04%	608 $16,000
Q3 2022 Nov 10, 2022	BUY	$22.62 - $32.54 $71,320 - $102,598	3,153 Added 34.64%	12,256 $284,000
Q2 2022 Aug 15, 2022	BUY	$22.88 - $39.45 $174,917 - $301,595	7,645 Added 524.35%	9,103 $229,000
Q1 2022 May 12, 2022	SELL	$31.69 - $43.29 $118,457 - $161,818	-3,738 Reduced 71.94%	1,458 $55,000
Q4 2021 Feb 14, 2022	BUY	$35.2 - $52.6 $71,984 - $107,567	2,045 Added 64.9%	5,196 $204,000
Q3 2021 Nov 15, 2021	BUY	$46.35 - $59.75 $84,913 - $109,462	1,832 Added 138.89%	3,151 $153,000
Q2 2021 Aug 16, 2021	SELL	$47.2 - $67.81 $96,712 - $138,942	-2,049 Reduced 60.84%	1,319 $69,000
Q1 2021 May 17, 2021	SELL	$30.93 - $59.48 $63,066 - $121,279	-2,039 Reduced 37.71%	3,368 $187,000
Q4 2020 Feb 16, 2021	BUY	$18.53 - $31.5 $68,950 - $117,211	3,721 Added 220.7%	5,407 $167,000
Q3 2020 Nov 16, 2020	SELL	$14.68 - $19.12 $187,375 - $244,047	-12,764 Reduced 88.33%	1,686 $31,000
Q2 2020 Aug 13, 2020	BUY	$8.5 - $15.82 $122,825 - $228,599	14,450 New	14,450 $200,000
Q4 2019 Feb 07, 2020	SELL	$13.77 - $19.2 $6,885 - $9,600	-500 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$14.93 - $19.83 $7,465 - $9,915	500 New	500 $8,000
Q1 2019 May 14, 2019	SELL	$16.23 - $20.29 $10,468 - $13,087	-645 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$10.77 - $18.44 $8,357 - $14,309	-776 Reduced 54.61%	645 $11,000
Q3 2018 Nov 13, 2018	BUY	$9.1 - $14.8 $11,083 - $18,026	1,218 Added 600.0%	1,421 $20,000
Q2 2018 Aug 15, 2018	BUY	$9.6 - $14.6 $1,948 - $2,963	203 New	203 $2,000
Q1 2018 May 15, 2018	SELL	$5.7 - $12.3 $34,690 - $74,857	-6,086 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$3.65 - $5.98 $14,789 - $24,230	4,052 Added 199.21%	6,086 $33,000
Q3 2017 Nov 14, 2017	BUY	$3.0 - $6.0 $6,102 - $12,204	2,034	2,034 $12,000

Others Institutions Holding VCEL

# of Institutions

276

Shares Held

48.8M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.7B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Vericel Corp Transaction History